You have   6 free profiles   left this month    Start Your Free Trial ➤
Hey, we noticed you're a RelSci Pro subscriber! Would you like to view the page there? View on RelSci Pro ➤

Jay A. Barth

Chief Medical Officer at Amicus Therapeutics, Inc.
Overview
Relationships
In The News
Paths
Education
Memberships
Career History
Public Holdings

Jay A. Barth

Chief Medical Officer at Amicus Therapeutics, Inc.

Overview

Age
54 (Born 1964)
Notable Companies
PTC Therapeutics, Inc.

Merck & Co., Inc.
Number of Relationships
This person is connected to 1,383 people.

Relationships See Details


Former Chief Financial Officer & Secretary at Amicus Therapeutics, Inc.

Senior Vice President, Human Resources at Amicus Therapeutics, Inc.

Chief Executive Officer at Amicus Therapeutics, Inc.

Former President & Chief Operating Officer at Amicus Therapeutics, Inc.

Chief Compliance Officer at Amicus Therapeutics, Inc.

Chief Science Officer at Amicus Therapeutics, Inc.

General Manager at Scioderm, Inc.

General Counsel & Corporate Secretary at Amicus Therapeutics, Inc.

Head-Investor & Media Relations at Amicus Therapeutics, Inc.

Co-Founder at PTC Therapeutics, Inc.
See 1,373 more listings with RelSci Professional.

In The News See More

GlobeNewswire
February 14, 2017
GlobeNewswire
July 12, 2016
PR Newswire
January 24, 2014
PR Newswire
October 1, 2013

Paths to Jay A. Barth

Jay A. Barth
You
Connections via Relationship Science
Jay A. Barth
Sync your contacts to see how you can connect with Jay A. Barth.

Educational Background

B.A. 
Columbia University is one of the world's most important centers of research and at the same time a distinctive and distinguished learning environment for undergraduates and graduate students in many scholarly and professional fields. The University recognizes the importance of its location in New York City and seeks to link its research and teaching to the vast resources of a great metropolis. It seeks to attract a diverse and international faculty and student body, to support research and teaching on global issues, and to create academic relationships with many countries and regions. It expects all areas of the university to advance knowledge and learning at the highest level and to convey the products of its efforts to the world.
MD 
The University of Pennsylvania is the oldest and one of the finest medical schools in the United States. Penn is rich in tradition and heritage and at the same time consistently at the forefront of new developments and innovations in medical education and research. Since its founding in 1765 the School has been a strong presence in the community and prides itself on educating the leaders of tomorrow in patient care, biomedical research, and medical education. At Penn academic excellence, as well as compassion for the patients we are privileged to serve, are stressed. Skillful compassion is truly a hallmark of the Penn learning experience. The Perelman School of Medicine at the University of Pennsylvania consistently ranks among the top five in US News and World Report’s rankings of research-oriented medical schools.

Memberships

Member
Current
TO CARRY OUT THE EDUCATIONAL, PRACTICE, AND RESEARCH INTERESTS OF THE AGA MEMBERS.
Member
Current
TO ADVANCE THE PRACTICE, STUDY AND SCIENCE OF GASTROENTEROLOGY
Member
Current

Career History

Chief Medical Officer
2014 - Current
Amicus Therapeutics, Inc. is a biotechnology company, which is engaged in the discovery, development and commercialization of novel treatments for patients living with rare and orphan diseases. Its product include migalastat HCl, which is a small molecule that can be used as a monotherapy and in combination with enzyme replacement therapy for fabry disease. The company was founded on February 4, 2002 and is headquartered in Cranbury, NJ.
Executive Director, Clinical Development
2009 - 2014
PTC Therapeutics, Inc. is a biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel medicines using its expertise in RNA biology. The company's internally discovered pipeline addresses multiple therapeutic areas, including rare disorders and oncology. It is focused on developing treatments to fundamentally change the lives of patients living with rare genetic disorders. The company was founded by Allan S. Jacobson and Stuart W. Peltz on March 31, 1998 and is headquartered in South Plainfield, NJ.
Executive Director-Clinical Research
2007 - 2008
Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.
Vice President-Clinical Research & Medical Affairs
2005 - 2007
ALTANA Pharma US, Inc. develops respiratory and gastrointestinal products. The company is headquartered in Florham Park, NJ.
Global Head-Gastroenterology Clinical Research
Prior

Public Holdings

Restricted data only for RelSci Professional users.

Other Affiliations

You've reached your 7 free profiles limit this month.

Upgrade to RelSci Pro today to enjoy unlimited profile views and much more!

Start My Free Trial
Still not convinced? Check out our full listing of features here.